false. my comment was that they cannot afford to fund a phase III trial. That is a true statement.
someone else running a phase iii trial on their behalf in an indication that most are not confident in succeeding is not enough to raise the SP unless results surprise.
they themselves need to be able to fund a trial in kidney disease for this to be worth something.
false. my comment was that they cannot afford to fund a phase...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $175.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 31.5¢ | $1.333M | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 727594 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 170412 | 4 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
32.0¢ |
Change
-0.015 ( 3.15 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 33.5¢ | 31.5¢ | 2261030 | ||
| Last updated 15.51pm 26/04/2024 ? | |||||
| DXB (ASX) Chart |